N@N

Joel Beatty Initiated (AXSM) at Buy and Held Target at $108 on, Mar 19th, 2024

Joel Beatty of Baird, Initiated "Axsome Therapeutics, Inc." (AXSM) at Buy and Held Target at $108 on, Mar 19th, 2024.

Joel has made no other calls on AXSM in the last 4 months.

There are 8 other peers that have a rating on AXSM. Out of the 8 peers that are also analyzing AXSM, 0 agree with Joel's Rating of Hold.

These are the ratings of the 8 analyists that currently disagree with Joel

---

• Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $180 on, Monday, March 4th, 2024
• Graig Suvannavejh of "Mizuho" Maintained at Strong Buy with Decreased Target to $108 on, Tuesday, February 27th, 2024
• Leonid Timashev of "RBC Capital" Maintained at Buy with Decreased Target to $123 on, Wednesday, February 21st, 2024
• Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $103 on, Wednesday, February 21st, 2024
• Yatin Suneja of "Guggenheim" Maintained at Strong Buy with Increased Target to $125 on, Wednesday, February 21st, 2024
• Ashwani Verma of "UBS" Initiated at Strong Buy and Held Target at $111 on, Tuesday, February 6th, 2024
• David Amsellem of "Piper Sandler" Maintained at Buy with Increased Target to $113 on, Tuesday, January 16th, 2024
• David Hoang of "Citigroup" Initiated at Strong Buy and Held Target at $125 on, Wednesday, December 13th, 2023

Contributing Sources

---